Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Abcuro announces pre-clinical data on new immuno-oncology target

First in vivo validation of KLRG1 as a new cancer immunotherapy target

Related or similar articles

March 13, 2019

Labshares Newton Grows its Business

Labshares is unveiling a major rennovation

March 13, 2019

Labshares Celebrates Grand Opening and Unveils Newly Expanded Shared Office and Lab Space in Newton

Labshares Newton's newly expanded facility features a cutting-edge lab and co-working space that can now accommodate up to 30 startups

June 28, 2024

Incubators vs. Shared Laboratories: Finding the Best Fit for Your Biotech Startup